The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease

OBJECTIVE: Thyroid-stimulating immunoglobulin (TSI) bioassay has a better ability to predict the relapse rate of Graves’ disease (GD) than the thyroid-stimulating hormone (TSH)-binding inhibitory immunoglobulin method in terms of measuring the TSH receptor antibody. However, the optimal TSI bioassay...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Han-Sang, Lee, Jaejun, Jeong, Chai-Ho, Lee, Jeongmin, Ha, Jeonghoon, Jo, Kwanhoon, Kim, Min-Hee, Cho, Jae Hyoung, Kang, Moo Il, Lim, Dong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012332/
https://www.ncbi.nlm.nih.gov/pubmed/35441120
http://dx.doi.org/10.1210/jendso/bvac023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012332/
https://www.ncbi.nlm.nih.gov/pubmed/35441120
http://dx.doi.org/10.1210/jendso/bvac023

Ejemplares similares